Rajendra Babu Munagala

Rajendra Babu Munagala

Active Director Additional Director DIN 01833246
DIN 01833246 First appointment Oct 2007 Primary industry Financial Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 4 active board seats
Past companies 3 historical roles
Total affiliations 7 Since Oct 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajendra Babu Munagala

Data last updated:

Rajendra Babu Munagala is an Additional Director at Srilakshya Credit And Investment Rating Agency Limited (since 2019), Designated Partner at Sai Dwarakamai Pharma Llp (since 2023) and Additional Director at Sai Sannidhi Pharmaceutical (India) Private Limited (since 2022), and holds 1 more current directorship. The companies operate in Financial Services, Paper and Pharma. The largest current company by reported revenue is Srilakshya Credit And Investment Rating Agency Limited at ₹66.6 Lakh (FY 2024). Earlier, Rajendra Babu Munagala was a Director at Sai Sannidhi Infra (India) Private Limited (2012–2015) and Director at Sri Sai Dwarakamai Mining Private Limited (from 2012) and 1 more.

DIN 01833246
Primary Designation Additional Director
Industry Financial Services
First Appointment 17 Oct 2007
Oldest Company Age 19 yrs
Largest company Srilakshya Credit And Investment Rating Agency Limited Β· ₹66.6 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director29 Mar 20192012₹66.6 Lakh (FY 2024)Active
Designated Partner08 Aug 20232023Active
Additional Director07 Feb 20222015Active
Designated Partner12 Sep 20182018Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Oct 20122012Strike Off
Director08 Aug 20122012Strike Off
Genuine Ites Private Limited U72200TG2007PTC055970
Director17 Oct 20072007₹7.2 Lakh (FY 2015)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sri Sai Dwarakamai Mining Private Limited
Sai Sannidhi Pharmaceutical (India) Private Limited
Genuine Ites Private Limited
Srilakshya Credit And Investment Rating Agency Limited
Premium access

Shareholding and investment profile for Rajendra Babu Munagala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajendra Babu Munagala

Rajendra Babu Munagala currently holds 4 directorships: Srilakshya Credit And Investment Rating Agency Limited (Additional Director, since 29 Mar 2019, revenue β‚Ή66.6 Lakh (FY 2024)); Sai Dwarakamai Pharma Llp (Designated Partner, since 08 Aug 2023); Sai Sannidhi Pharmaceutical (India) Private Limited (Additional Director, since 07 Feb 2022); Sri Sai Dwarakamai Infra Llp (Designated Partner, since 12 Sep 2018).

Rajendra Babu Munagala was first appointed on 17 Oct 2007 as Director at Genuine Ites Private Limited. The most recent appointment on record is 08 Aug 2023 at Sai Dwarakamai Pharma Llp.

Rajendra Babu Munagala held 3 earlier board appointments: Sai Sannidhi Infra (India) Private Limited (Director, 12 Oct 2012 to 03 Oct 2015); Sri Sai Dwarakamai Mining Private Limited (Director, from 08 Aug 2012); Genuine Ites Private Limited (Director, from 17 Oct 2007).

The current boards of Rajendra Babu Munagala's companies include Ashok Kumar Dogra (Srilakshya Credit And Investment Rating Agency Limited), Sharafudheen Abdulkadir Parilakathoottu (Srilakshya Credit And Investment Rating Agency Limited), Singaravelu Rajaraman (Srilakshya Credit And Investment Rating Agency Limited), Deepthi Somisetty (Sai Dwarakamai Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available